409 related articles for article (PubMed ID: 20167946)
1. Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.
Lee A; Chick JM; Kolarich D; Haynes PA; Robertson GR; Tsoli M; Jankova L; Clarke SJ; Packer NH; Baker MS
Mol Cell Proteomics; 2011 Sep; 10(9):M900538MCP200. PubMed ID: 20167946
[TBL] [Abstract][Full Text] [Related]
2. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
3. Tumour suppressor p16(INK4a) - anoikis-favouring decrease in N/O-glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model.
Amano M; Eriksson H; Manning JC; Detjen KM; André S; Nishimura S; Lehtiö J; Gabius HJ
FEBS J; 2012 Nov; 279(21):4062-80. PubMed ID: 22943525
[TBL] [Abstract][Full Text] [Related]
4. Terminal Galactosylation and Sialylation Switching on Membrane Glycoproteins upon TNF-Alpha-Induced Insulin Resistance in Adipocytes.
Parker BL; Thaysen-Andersen M; Fazakerley DJ; Holliday M; Packer NH; James DE
Mol Cell Proteomics; 2016 Jan; 15(1):141-53. PubMed ID: 26537798
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies.
Chik JH; Zhou J; Moh ES; Christopherson R; Clarke SJ; Molloy MP; Packer NH
J Proteomics; 2014 Aug; 108():146-62. PubMed ID: 24840470
[TBL] [Abstract][Full Text] [Related]
6. Integrated Systems Analysis of the Murine and Human Pancreatic Cancer Glycomes Reveals a Tumor-Promoting Role for ST6GAL1.
Kurz E; Chen S; Vucic E; Baptiste G; Loomis C; Agrawal P; Hajdu C; Bar-Sagi D; Mahal LK
Mol Cell Proteomics; 2021; 20():100160. PubMed ID: 34634466
[TBL] [Abstract][Full Text] [Related]
7. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation.
Martin LT; Marth JD; Varki A; Varki NM
J Biol Chem; 2002 Sep; 277(36):32930-8. PubMed ID: 12068010
[TBL] [Abstract][Full Text] [Related]
8. ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.
Holdbrooks AT; Britain CM; Bellis SL
J Biol Chem; 2018 Feb; 293(5):1610-1622. PubMed ID: 29233887
[TBL] [Abstract][Full Text] [Related]
9. Defining the glycophenotype of squamous epithelia using plant and mammalian lectins. Differentiation-dependent expression of alpha2,6- and alpha2,3-linked N-acetylneuraminic acid in squamous epithelia and carcinomas, and its differential effect on binding of the endogenous lectins galectins-1 and -3.
Holíková Z; Hrdlicková-Cela E; Plzák J; Smetana K; Betka J; Dvoránková B; Esner M; Wasano K; André S; Kaltner H; Motlík J; Hercogová J; Kodet R; Gabius HJ
APMIS; 2002 Dec; 110(12):845-56. PubMed ID: 12645662
[TBL] [Abstract][Full Text] [Related]
10. A Golgi-associated redox switch regulates catalytic activation and cooperative functioning of ST6Gal-I with B4GalT-I.
Hassinen A; Khoder-Agha F; Khosrowabadi E; Mennerich D; Harrus D; Noel M; Dimova EY; Glumoff T; Harduin-Lepers A; Kietzmann T; Kellokumpu S
Redox Biol; 2019 Jun; 24():101182. PubMed ID: 30959459
[TBL] [Abstract][Full Text] [Related]
11. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.
Solatycka A; Owczarek T; Piller F; Piller V; Pula B; Wojciech L; Podhorska-Okolow M; Dziegiel P; Ugorski M
Glycobiology; 2012 Aug; 22(8):1042-54. PubMed ID: 22534569
[TBL] [Abstract][Full Text] [Related]
12. Rho GTPase Rac1: molecular switch within the galectin network and for N-glycan α2,6-sialylation/O-glycan core 1 sialylation in colon cancer in vitro.
André S; Singh T; Lacal JC; Smetana K; Gabius HJ
Folia Biol (Praha); 2014; 60(3):95-107. PubMed ID: 25056432
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of α2,3-linked sialic acids promotes gastric cancer cell metastasis and correlates with poor prognosis.
Shen L; Luo Z; Wu J; Qiu L; Luo M; Ke Q; Dong X
Int J Oncol; 2017 Apr; 50(4):1201-1210. PubMed ID: 28259967
[TBL] [Abstract][Full Text] [Related]
14. Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers.
Lu J; Gu J
Molecules; 2015 Apr; 20(5):7509-27. PubMed ID: 25919275
[TBL] [Abstract][Full Text] [Related]
15. Sialylation on O-glycans protects platelets from clearance by liver Kupffer cells.
Li Y; Fu J; Ling Y; Yago T; McDaniel JM; Song J; Bai X; Kondo Y; Qin Y; Hoover C; McGee S; Shao B; Liu Z; Sonon R; Azadi P; Marth JD; McEver RP; Ruan C; Xia L
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8360-8365. PubMed ID: 28716912
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of ST3Gal-I promotes mammary tumorigenesis.
Picco G; Julien S; Brockhausen I; Beatson R; Antonopoulos A; Haslam S; Mandel U; Dell A; Pinder S; Taylor-Papadimitriou J; Burchell J
Glycobiology; 2010 Oct; 20(10):1241-50. PubMed ID: 20534593
[TBL] [Abstract][Full Text] [Related]
17. ST6Gal-I regulates macrophage apoptosis via α2-6 sialylation of the TNFR1 death receptor.
Liu Z; Swindall AF; Kesterson RA; Schoeb TR; Bullard DC; Bellis SL
J Biol Chem; 2011 Nov; 286(45):39654-62. PubMed ID: 21930713
[TBL] [Abstract][Full Text] [Related]
18. Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells.
Dimitroff CJ; Pera P; Dall'Olio F; Matta KL; Chandrasekaran EV; Lau JT; Bernacki RJ
Biochem Biophys Res Commun; 1999 Mar; 256(3):631-6. PubMed ID: 10080950
[TBL] [Abstract][Full Text] [Related]
19. Human B Cell Differentiation Is Characterized by Progressive Remodeling of O-Linked Glycans.
Giovannone N; Antonopoulos A; Liang J; Geddes Sweeney J; Kudelka MR; King SL; Lee GS; Cummings RD; Dell A; Barthel SR; Widlund HR; Haslam SM; Dimitroff CJ
Front Immunol; 2018; 9():2857. PubMed ID: 30619255
[TBL] [Abstract][Full Text] [Related]
20. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death.
Amano M; Galvan M; He J; Baum LG
J Biol Chem; 2003 Feb; 278(9):7469-75. PubMed ID: 12499376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
